Onfekafusp alfa for sarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Aug 2020: Trial started, NCT04733183
  2. 1 Feb 2021: Trial registered, NCT04733183

The trials

NCT04733183: Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue Sarcoma

State
Under way
Phase
Phase 2
People
98 planned
Started
28 Aug 2020
Primary completion
Dec 2025
Arms
Arm1: DTIC + L19TNF
Results
None posted
  1. 28 Aug 2020: Trial started
  2. 1 Feb 2021: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as L19TNF.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.